2017 - Global Drug Survey (GDS) Global Overview and Highlights.pdf

(17361 KB) Pobierz
Prepared by the GDS Core Research Team
Dr Adam Winstock, Dr Monica Barratt, Dr Jason Ferris & Dr Larissa Maier
Global overview and highlights
N > 115,000
Global Drug Survey GDS2017 © Not to be reproduced without authors permission
Hi everyone
On behalf of the GDS Core Research Team and everyone of our amazing international network partners and supportive
media organisations we’d like to share our headline report deck. I know it won’t have everything that everyone wants
but we are hopeful it will give people an idea of how the world of drugs is changing and highlight some of the key
things that we think people can better engage with to keep themselves and those they care for safe.
Once we cleaned the data from 150,000 people we chose to use data from just under 120,000 people this year for
these reports. We have data reports addressing 18 different areas for over 25 countries. We can only share a fraction
of what we have here on the site. However, we are very open to sharing the other findings we have and would ask
researchers and public health groups to contact us so we can discuss funding and collaboration.
We have almost completed designing GDS2018 so that we can start piloting early and give countries where we have
not yet found friends to reach out to us. We particularly want to hear from people in Japan, Eastern Europe, Africa and
the Middle East.
Dr Adam R Winstock Founder and CEO Global Drug Survey
Consultant Psychiatrist and Addiction Medicine Specialist
Global Drug Survey GDS2017 © Not to be reproduced without authors permission
We think this will be interesting
.
We hope you enjoy this report
which we gladly share with
you with for free. If you like what
Global Drug Survey does
then we’d like to ask
you to make the smallest of
donations – the price of joint, a pill, a line, a beer (£10).
Your donation will help us carry on being independent, run the survey and encourage
governments, communities and people to have honest conversations about drugs.
Thank you
Adam on behalf of GDS
Global Drug Survey
runs the world’s largest drug survey
This report is embargoed until
Wednesday May 24th 2017
Using and reporting the data
In all copy related to the data provided the study should be referred to as
Global Drug Survey 2017
For further information and requests for local country and bespoke data
reports please contact adam@globaldrugsurvey.com
Global Drug Survey GDS2017 © Not to be reproduced without authors permission
Global Drug Survey 2017
A total of 119,846 people from over 50 countries
participated in GDS2017. Of these 115,523 had their data
used in the preparation of these reports .
Mission
We aim to make drug use safer regardless of the legal
status by sharing information in a credible and
meaningful way.
Our last 4 surveys, run at the end of 2013, 2014,
2015, and 2016 received over 400,000 responses.
GDS is an independent global drug use data exchange hub
that conducts university ethics approved, anonymous on-
line surveys. We collaborate with global media partners
who act as hubs to promote our work.
GDS is comprised of experts from the fields of medicine,
toxicology, public health, psychology, chemistry, public
policy, criminology, sociology, harm reduction and
addiction. We research key issues of relevance and
importance to both people who use drugs and those who
craft public health and drug policy
Over the last decade GDS has successfully supported
the widespread dissemination of essential information
both to people who use drugs through our media
partners and to the medical profession through
academic papers, presentation at international
conferences, expert advisory meetings and through
www.drugsmeter.com
and www.drinksmeter.com
Global Drug Survey GDS2017 © Not to be reproduced without authors permission
Zgłoś jeśli naruszono regulamin